Literature DB >> 19412386

Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis.

Donna McRitchie1, Warda Farooq, Harold N Fisher.   

Abstract

Entities:  

Year:  2008        PMID： 19412386      PMCID： PMC2605876          DOI： 10.1155/2008/501759

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  8 in total

Review 1.  The cytoprotective protein C pathway.

Authors:  Laurent O Mosnier; Berislav V Zlokovic; John H Griffin
Journal:  Blood       Date:  2006-11-16       Impact factor: 22.113

2.  A cluster of cases of severe acute respiratory syndrome in Hong Kong.

Authors:  Kenneth W Tsang; Pak L Ho; Gaik C Ooi; Wilson K Yee; Teresa Wang; Moira Chan-Yeung; Wah K Lam; Wing H Seto; Loretta Y Yam; Thomas M Cheung; Poon C Wong; Bing Lam; Mary S Ip; Jane Chan; Kwok Y Yuen; Kar N Lai
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

3.  Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated).

Authors:  Steven M Opal; Gary E Garber; Steven P LaRosa; Dennis G Maki; Ross C Freebairn; Gary T Kinasewitz; Jean-Francois Dhainaut; S Betty Yan; Mark D Williams; Delores E Graham; David R Nelson; Howard Levy; Gordon R Bernard
Journal:  Clin Infect Dis       Date:  2003-06-24       Impact factor: 9.079

4.  Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.

Authors:  Christopher M Booth; Larissa M Matukas; George A Tomlinson; Anita R Rachlis; David B Rose; Hy A Dwosh; Sharon L Walmsley; Tony Mazzulli; Monica Avendano; Peter Derkach; Issa E Ephtimios; Ian Kitai; Barbara D Mederski; Steven B Shadowitz; Wayne L Gold; Laura A Hawryluck; Elizabeth Rea; Jordan S Chenkin; David W Cescon; Susan M Poutanen; Allan S Detsky
Journal:  JAMA       Date:  2003-05-06       Impact factor: 56.272

5.  Critically ill patients with severe acute respiratory syndrome.

Authors:  Robert A Fowler; Stephen E Lapinsky; David Hallett; Allan S Detsky; William J Sibbald; Arthur S Slutsky; Thomas E Stewart
Journal:  JAMA       Date:  2003-07-16       Impact factor: 56.272

6.  Guidance on patient identification and administration of recombinant human activated protein C for the treatment of severe sepsis.

Authors:  Gary Garber; Rt Noel Gibney; Bruce Light; Claudio Martin; Kenneth Cunningham; Jean-Gilles Guimond; Sheldon Magder; James Russell
Journal:  Can J Infect Dis       Date:  2002-11

7.  Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.

Authors:  Thomas W K Lew; Tong-Kiat Kwek; Dessmon Tai; Arul Earnest; Shi Loo; Kulgit Singh; Kim Meng Kwan; Yeow Chan; Chik Foo Yim; Siam Lee Bek; Ai Ching Kor; Wee See Yap; Y Rubuen Chelliah; Yeow Choy Lai; Soon-Keng Goh
Journal:  JAMA       Date:  2003-07-16       Impact factor: 56.272

Review 8.  New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).

Authors:  William L Macias; S Betty Yan; Mark D Williams; Suzane L Um; George E Sandusky; Darryl W Ballard; Jean-Michel S Planquois
Journal:  Crit Care       Date:  2005-08-25       Impact factor: 9.097
  8 in total
  1 in total

1.  Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: a prospective observational cohort study.

Authors:  Ming-Tzer Lin; Yu-Feng Wei; Shih-Chi Ku; Chih-An Lin; Chao-Chi Ho; Chong-Jen Yu
Journal:  J Formos Med Assoc       Date:  2010-11       Impact factor: 3.282
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.